Cognitive behavior therapy for psychological distress in parents of childhood cancer survivors

• Register: ISRCTN
• Last refreshed on: 27 May 2019
• Main ID: ISRCTN74785895
• Date of registration: 08/03/2017
• Prospective Registration: No
• Primary sponsor: Uppsala University
• Public title: Cognitive behavior therapy for psychological distress in parents of childhood cancer survivors
• Scientific title: Development and preliminary evaluation of Individualized face-to-face cognitive behavior therapy for psychological distress in parents of childhood cancer survivors
• Date of first enrolment: 01/02/2013
• Target sample size: 20
• Recruitment status: Completed
• URL: http://isrctn.com/ISRCTN74785895
• Study type: Interventional
• Study design: Single-group non-randomised open trial (Treatment)
• Phase: Not Applicable

Countries of recruitment

Sweden

Contacts

• Name: Martin Cernvall

Key inclusion & exclusion criteria

Inclusion criteria:
1. Parents of children who have finished a successful cancer treatment 3 months to 5 years previously
2. Who experience suffering that they relate to the child's disease
3. Swedish speaking
4. Live relatively close to Uppsala, Västerås or Gävle

Exclusion criteria:
1. Suffer from a psychiatric disorder in immediate need of treatment
2. In psychotherapy
3. If they have suicidal ideations


Age minimum:
Age maximum:
Gender: Both

Health Condition(s) or Problem(s) studied

Psychological distress (posttraumatic stress, depression, anxiety)
Mental and Behavioural Disorders

Intervention(s)

Included parents are offered 10-15 weekly 45-minute sessions of individual CBT provided by two resident psychologists under supervision. Psychological distress (post-traumatic stress, depression, anxiety) is assessed before treatment, at the end of treatment, and at 3-months follow-up.

Primary Outcome(s)

1. Post-traumatic stress symptoms, assessed with the The PTSD Checklist - Civilian (PCL-C) at baseline, post-treatment and at 3 months after end of treatment
2. Depression, assessed with the Montgomery Åsberg Depression Rating Scale Self-assessment (MADRS-S) at baseline, post-treatment and at 3 months after end of treatment
3. Anxiety, assessed with the Beck Anxiety Inventory (BAI) at baseline, post-treatment and at 3 months after end of treatment

Secondary Outcome(s)

1. Experiential avoidance, assessed with the Acceptance and Action Questionnaire (AAQ-II) at baseline, post-treatment and at 3 months after end of treatment
2. Worry, assessed with the Penn State Worry Questionnaire (PSWQ) at baseline, post-treatment and at 3 months after end of treatment
3. Rumination, assessed with the Rumination Scale of the Response Style Questionnaire (RSQ) at baseline, post-treatment and at 3 months after end of treatment
4. Perceived quality of life, assessed with the Satisfaction with Life Scale (SWLS) at baseline, post-treatment and at 3 months after end of treatment
5. The presence of psychiatric disorders, assessed with the Mini-International Neuropsychiatric Interview (M.I.N.I), a structured diagnostic psychiatric interview for DSM-IV and ICD-10, at baseline, post-treatment and at 3 months after end of treatment

Secondary ID(s)

Petra

Source(s) of Monetary Support

Vetenskapsrådet, Cancerfonden

Ethics review

Status:
Approval date:
Contact:

Regional Ethics Committee of Uppsala, 17/12/2012, Dnr: 2012/440

Results

• Results available: Yes
• Date Completed: 04/12/2015